|
1
|
Jemal A, Tiwari RC, Murray T, et al:
Cancer statistics, 2004. CA Cancer J Clin. 54:8–29. 2004.
View Article : Google Scholar
|
|
2
|
Moss C and Kaye SB: Ovarian cancer:
progress and continuing controversies in management. Eur J Cancer.
38:1701–1707. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
4
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tavazoie SF, Alarcón C, Oskarsson T, et
al: Endogenous human microRNAs that suppress breast cancer
metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Y, Zhao F, Wang Z, et al: microRNA-335
acts as a metastasis suppressor in gastric cancer by targeting
Bcl-w and specificity protein 1. Oncogene. 31:1398–1407. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lynch J, Fay J, Meehan M, et al: miRNA-335
suppresses neuroblastoma cell invasiveness by direct targeting of
multiple genes from the non-canonical TGF-β signalling pathway.
Carcinogenesis. 33:976–985. 2012.PubMed/NCBI
|
|
8
|
Schmitz KJ, Helwig J, Bertram S, et al:
Differential expression of microRNA-675, microRNA-139–3p and
microRNA-335 in benign and malignant adrenocortical tumours. J Clin
Pathol. 64:529–535. 2011.PubMed/NCBI
|
|
9
|
Shu M, Zhou Y, Zhu W, et al: microRNA 335
is required for differentiation of malignant glioma cells induced
by activation of cAMP/protein kinase A pathway. Mol Pharmacol.
81:292–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dahiya N, Sherman-Baust CA, Wang TL, et
al: microRNA expression and identification of putative miRNA
targets in ovarian cancer. PLoS One. 3:e24362008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sorrentino A, Liu CG, Addario A, Peschle
C, Scambia G and Ferlini C: Role of microRNAs in drug-resistant
ovarian cancer cells. Gynecol Oncol. 111:478–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wyman SK, Parkin RK, Mitchell PS, et al:
Repertoire of microRNAs in epithelial ovarian cancer as determined
by next generation sequencing of small RNA cDNA libraries. PLoS
One. 4:e53112009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bae IH, Park MJ, Yoon SH, et al: Bcl-w
promotes gastric cancer cell invasion by inducing matrix
metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt,
and Sp1. Cancer Res. 66:4991–4995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HW, Lee SS, Lee SJ and Um HD: Bcl-w is
expressed in a majority of infiltrative gastric adenocarcinomas and
suppresses the cancer cell death by blocking stress-activated
protein kinase/c-Jun NH2-terminal kinase activation.
Cancer Res. 63:1093–1100. 2003.PubMed/NCBI
|
|
15
|
Wilson JW, Nostro MC, Balzi M, et al:
Bcl-w expression in colorectal adenocarcinoma. Br J Cancer.
82:178–185. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kitamura S, Kondo S, Shinomura Y, et al:
Met/HGF receptor modulates bcl-w expression and inhibits apoptosis
in human colorectal cancers. Br J Cancer. 83:668–673. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lü MH, Li CZ, Hu CJ, et al: microRNA-27b
suppresses mouse MSC migration to the liver by targeting SDF-1α in
vitro. Biochem Biophys Res Commun. 421:389–395. 2012.PubMed/NCBI
|
|
18
|
Moore LD, Isayeva T, Siegal GP and
Ponnazhagan S: Silencing of transforming growth factor-β1 in situ
by RNA interference for breast cancer: implications for
proliferation and migration in vitro and metastasis in vivo. Clin
Cancer Res. 14:4961–4970. 2008.
|
|
19
|
Corney DC, Hwang CI, Matoso A, et al:
Frequent downregulation of miR-34 family in human ovarian cancers.
Clin Cancer Res. 16:1119–1128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan X, Liu Y, Jiang J, et al: miR-20a
promotes proliferation and invasion by targeting APP in human
ovarian cancer cells. Acta Biochim Biophys Sin. 42:318–324. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Liang S, Yu H, Zhang J, Ma D and Lu
X: An inhibitory effect of miR-22 on cell migration and invasion in
ovarian cancer. Gynecol Oncol. 119:543–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lou Y, Yang X, Wang F, Cui Z and Huang Y:
MicroRNA-21 promotes the cell proliferation, invasion and migration
abilities in ovarian epithelial carcinomas through inhibiting the
expression of PTEN protein. Int J Mol Med. 26:819–827.
2010.PubMed/NCBI
|
|
23
|
Tsuda N, Kawano K, Efferson CL and
Ioannides CG: Synthetic microRNA and double-stranded RNA targeting
the 3′-untranslated region of HER-2/neu mRNA inhibit HER-2 protein
expression in ovarian cancer cells. Int J Oncol. 27:1299–1306.
2005.
|
|
24
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family ‘killer-proteins’ and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001.
|
|
25
|
Bae IH, Yoon SH, Lee SB, Park JK, Ho JN
and Um HD: Signaling components involved in Bcl-w-induced migration
of gastric cancer cells. Cancer Lett. 277:22–28. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Uren RT, Dewson G, Chen L, et al:
Mitochondrial permeabilization relies on BH3 ligands engaging
multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol.
177:277–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhivotovsky B and Orrenius S:
Carcinogenesis and apoptosis: paradigms and paradoxes.
Carcinogenesis. 27:1939–1945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim EM, Kim J, Park JK, et al: Bcl-w
promotes cell invasion by blocking the invasion-suppressing action
of Bax. Cell Signal. 24:1163–1172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans.
Cell. 75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
